Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-754807 plus Trastuzumab in Advanced HER2+ Breast Cancer
NCT00788333Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of BMS-754807 in breast cancer, sponsored by Bristol Myers Squibb. Started Jul 2009; status: completed.
02
Drugs
BMS-754807
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00788333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788333.